FDA Approves DAPAGLIFLOZIN — AvKARE
# FDA Approves AvKARE's Generic Dapagliflozin AvKARE has received FDA approval for its generic dapagliflozin oral formulation, marking another entry into the competitive SGLT2 inh…
SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
# FDA Approves AvKARE's Generic Dapagliflozin AvKARE has received FDA approval for its generic dapagliflozin oral formulation, marking another entry into the competitive SGLT2 inh…
# FDA Approves Generic DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE Combination Macleods Pharmaceuticals Limited received FDA approval for its generic dapagliflozin and metformin hyd…
# FDA Approves Generic Dapagliflozin from Alembic Pharmaceuticals The U.S. FDA has approved Alembic Pharmaceuticals Limited's generic dapagliflozin oral formulation, expanding com…
Sun Pharmaceutical Industries, Inc. secured FDA approval for its oral generic Dapagliflozin and Metformin Hydrochloride tablets, positioning the company to expand its competitive p…
Cipla USA Inc. secured FDA approval for its generic oral tablet of Dapagliflozin, positioning the manufacturer to capture market share in the growing diabetes treatment sector. Thi…
Biocon Pharma Inc. secured FDA approval for its generic oral formulation of Dapagliflozin via ANDA211470, with the product slated for a market entry in April 2026. This regulatory …
Ascend Laboratories received FDA approval for its Generic Dapagliflozin and Metformin Hydrochloride tablets, a critical oral combination therapy for type 2 diabetes. This launch is…
The FDA has granted full approval to generic dapagliflozin manufactured by Apotex Corp., paving the way for the company to capture market share in the widely prescribed SGLT2 inhib…
# FDA Approves Baxter Healthcare's Generic Phenylephrine Hydrochloride Injection Baxter Healthcare Corporation has received FDA approval for its generic phenylephrine hydrochlorid…
# FDA Approves Sandoz's Generic Nintedanib, Expanding Competition in Pulmonary Fibrosis Market Sandoz Inc. has received FDA approval for its generic nintedanib esylate oral formul…
# FDA Approves Dr. Reddy's Laboratories' Generic Nintedanib Dr. Reddy's Laboratories Inc. received FDA approval for its generic nintedanib esylate oral formulation (ANDA219283), m…
# FDA Approves Generic Version of Nintedanib, Enabling Significant Cost Savings for Pulmonary Fibrosis Patients Apotex Corp. has received FDA approval for a generic formulation of…
# FDA Approves Generic Nintedanib Capsules; Exelan Pharmaceuticals Enters Competitive Pulmonary Fibrosis Market Exelan Pharmaceuticals Inc. has received FDA approval for generic n…
Edenbridge Pharmaceuticals LLC has received FDA approval for its ANDA219819 application for Nintedanib Esyslate tablets, strengthening the firm’s portfolio with the generic version…
# FDA Approves Eli Lilly's FOUNDAYO for Oral Administration Eli Lilly and Company received FDA approval for FOUNDAYO (orforglipron calcium), an oral medication that expands the co…
# FDA Approves KLM Laboratories' Generic Mesalamine Rectal Formulation KLM Laboratories Private Limited received FDA approval for its generic mesalamine rectal formulation (ANDA22…
# FDA Approves Generic Olmesartan Medoxomil and Hydrochlorothiazide Combination ScieGen Pharmaceuticals Inc received FDA approval for a generic version of olmesartan medoxomil and…
# FDA Approves Baxter Healthcare's Intramuscular Epinephrine Formulation Baxter Healthcare Corporation received FDA approval for its intramuscular epinephrine formulation (NDA2206…
On March 26, 2026, SAGENT received FDA approval for a new drug, signaling a strategic entry into the market with potential to compete against existing products. The approval is poi…
# FDA Approves Denali Therapeutics' AVLAYAH, Expanding Its Neurology Portfolio Denali Therapeutics Inc. received FDA approval for AVLAYAH (tividenofusp alfa-eknm), an intravenous …